Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share

v3.19.3.a.u2
Earnings Per Share
3 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
Earnings Per Share

The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective balance sheet date.  At December 31, 2019 and 2018, potential dilutive effects, representing approximately 256,000 and 400,000 shares, respectively, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future.
 
Three Months Ended
December 31,
 
2019
 
2018
Net (loss) income attributable to Hillenbrand
$
(3.1
)
 
$
28.3

Weighted average shares outstanding (basic - in millions) (1)
68.4

 
62.9

Effect of dilutive stock options and other unvested equity awards (in millions) (2)

 
0.6

Weighted average shares outstanding (diluted - in millions)
68.4

 
63.5

 
 
 
 
Basic (loss) earnings per share
$
(0.05
)
 
$
0.45

Diluted (loss) earnings per share
$
(0.05
)
 
$
0.45

 
 
 
 
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)
2.4

 
0.7


 
 
(1) 
The increase in weighted average shares outstanding during the current quarter was due to 11.9 million of additional shares issued on November 21, 2019 in connection with the acquisition of Milacron. See Note 4 for further information.
(2) 
As a result of the net loss attributable to Hillenbrand during the three months ended December 31, 2019, the effect of stock options and other unvested equity awards would be antidilutive. In accordance with GAAP, they have been excluded from the diluted EPS calculation.